Steffen Goletz, PhD

Full Professor, Head of Biotherapeutic Glycoengineering and Immunology - Institute for Biotechnology & Biomedicine at Danish Technical University

Speaker

PhD, Professor, Head of RG Biotherapeutic Glycoengineering & Immunology, DTU Bioengineering, Technical University of Denmark. Focus on novel bi- and multispecific antibody and cell-based therapeutics in immunooncology and infectious diseases. After early career in academic research, e.g. MDC in Berlin and MRC in Cambridge, SG founded, lead and matured Biotech companies successfully as CEO and CSO over >17 years before joining DTU as professor, Deputy Head of the Department and Head of Innovation & Entrepreneurship. Extensive experience in Strategic & Corporate Development, Investor Financing & Licensing, R&D, patenting and GMP manufacturing, incl. Early Research & Discovery, Preclinical Development, Process Development, Toxicology of Biopharmaceuticals, and Clinical Development and from FIM to larger PhIIb Studies. Heading R&D of biotherapeutic antibodies and proteins, complex antibody engineering, phage display, cellular and molecular glycoengineering, mammalian production cell system engineering, USP and DSP production process development. Heading GMP-production, preclinical and clinical development.